A Study of Brenipatide in Adult Participants With Schizophrenia

NCT07410507 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Brenipatide
DRUG: Placebo

Sponsor

Eli Lilly and Company